
Oluwatosin A. Ogunbiyi
Examiner (ID: 9383, Phone: (571)272-9939 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1113 |
| Issued Applications | 596 |
| Pending Applications | 141 |
| Abandoned Applications | 402 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18970454
[patent_doc_number] => 20240050546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/028477
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028477
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028477 | VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS | Sep 27, 2021 | Pending |
Array
(
[id] => 18893804
[patent_doc_number] => 20240009289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/251658
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251658
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251658 | THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE | Sep 23, 2021 | Pending |
Array
(
[id] => 17334620
[patent_doc_number] => 20220000951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => Lactobacillus Crispatus KBL693 Strain and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/448620
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/448620 | Lactobacillus crispatus KBL693 strain and use thereof | Sep 22, 2021 | Issued |
Array
(
[id] => 17312914
[patent_doc_number] => 20210401962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => VACCINE FOR PREVENTION OF NECROTIC ENTERITIS IN POULTRY
[patent_app_type] => utility
[patent_app_number] => 17/474797
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474797 | Vaccine for prevention of necrotic enteritis in poultry | Sep 13, 2021 | Issued |
Array
(
[id] => 20536812
[patent_doc_number] => 12553883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Methods and uses of microbiome compositions
[patent_app_type] => utility
[patent_app_number] => 17/472189
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 14
[patent_no_of_words] => 11151
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472189 | Methods and uses of microbiome compositions | Sep 9, 2021 | Issued |
Array
(
[id] => 18691025
[patent_doc_number] => 20230321213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => OUTER MEMBRANE VESICLES
[patent_app_type] => utility
[patent_app_number] => 18/025273
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025273
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025273 | OUTER MEMBRANE VESICLES | Sep 8, 2021 | Pending |
Array
(
[id] => 20179489
[patent_doc_number] => 20250263447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS
[patent_app_type] => utility
[patent_app_number] => 18/043595
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043595
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043595 | OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS | Sep 2, 2021 | Pending |
Array
(
[id] => 17383985
[patent_doc_number] => 20220031837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/412550
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412550 | PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS | Aug 25, 2021 | Abandoned |
Array
(
[id] => 18690984
[patent_doc_number] => 20230321162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => MICROBIAL STRAINS AND ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 18/022400
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022400 | Microbial strains and antibiotics | Aug 17, 2021 | Issued |
Array
(
[id] => 18691032
[patent_doc_number] => 20230321222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Immune Adjuvant Comprising Hepatitis B Virus-Derived Polypeptide
[patent_app_type] => utility
[patent_app_number] => 18/021261
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021261
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021261 | Immune adjuvant comprising hepatitis B virus-derived polypeptide | Aug 11, 2021 | Issued |
Array
(
[id] => 17256848
[patent_doc_number] => 20210369833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => BACTERIAL POLYSACCHARIDE-CONJUGATED CARRIER PROTEINS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/399944
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399944 | BACTERIAL POLYSACCHARIDE-CONJUGATED CARRIER PROTEINS AND USE THEREOF | Aug 10, 2021 | Abandoned |
Array
(
[id] => 18921446
[patent_doc_number] => 20240024450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => NEISSERIAL SURFACE PROTEIN A (NSPA) VARIANTS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/040134
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040134 | Neisserial surface protein a (NSPA) variants and methods of use thereof | Aug 5, 2021 | Issued |
Array
(
[id] => 18777869
[patent_doc_number] => 11819545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
[patent_app_type] => utility
[patent_app_number] => 17/392066
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4841
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392066 | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology | Aug 1, 2021 | Issued |
Array
(
[id] => 18612412
[patent_doc_number] => 20230279144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ANTI-HER2 ANTIBODY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/007262
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007262
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007262 | ANTI-HER2 ANTIBODY AND USE THEREOF | Jul 26, 2021 | Pending |
Array
(
[id] => 17312865
[patent_doc_number] => 20210401913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Treatment of Warts
[patent_app_type] => utility
[patent_app_number] => 17/378411
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378411 | Treatment of warts | Jul 15, 2021 | Issued |
Array
(
[id] => 18724305
[patent_doc_number] => 20230338439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => COMPOSITION FOR TREATING BRAIN DISEASE COMPRISING PEDIOCOCCUS INOPINATUS OR EXTRACELLULAR VESICLES ISOLATED THEREFROM AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/015783
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015783 | COMPOSITION FOR TREATING BRAIN DISEASE COMPRISING PEDIOCOCCUS INOPINATUS OR EXTRACELLULAR VESICLES ISOLATED THEREFROM AS ACTIVE INGREDIENT | Jul 12, 2021 | Pending |
Array
(
[id] => 20076289
[patent_doc_number] => 12350324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Streptococcal vaccines
[patent_app_type] => utility
[patent_app_number] => 18/016298
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 30
[patent_no_of_words] => 13768
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016298
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/016298 | Streptococcal vaccines | Jul 11, 2021 | Issued |
Array
(
[id] => 18647876
[patent_doc_number] => 20230293652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => IMMUNOSTIMULATORY ADJUVANTS
[patent_app_type] => utility
[patent_app_number] => 18/014581
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -256
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014581 | IMMUNOSTIMULATORY ADJUVANTS | Jul 6, 2021 | Pending |
Array
(
[id] => 18691023
[patent_doc_number] => 20230321211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Genetically engineered live bacteria and methods of constructing the same
[patent_app_type] => utility
[patent_app_number] => 18/002044
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002044
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002044 | Genetically engineered live bacteria and methods of constructing the same | Jul 4, 2021 | Issued |
Array
(
[id] => 17312758
[patent_doc_number] => 20210401806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF VAGINAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/363193
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363193 | Compositions and methods for treatment of vaginal infections | Jun 29, 2021 | Issued |